A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.
about
C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancerMetastasis suppressor genesMetastasis suppressor genes at the interface between the environment and tumor cell growthCK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation.BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer.In vitro biophysical, microspectroscopic and cytotoxic evaluation of metastatic and non-metastatic cancer cells in responses to anti-cancer drug.Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analysesFascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated moleculesCytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.Polymorphisms in the DNA repair gene ERCC2/XPD and breast cancer risk: a HapMap-based case-control study among Han Women in a Chinese less-developed areaGenomics screens for metastasis genesThe C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression.Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppressionERα Mediates Estrogen-Induced Expression of the Breast Cancer Metastasis Suppressor Gene BRMS1.Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.Metastasis suppressors in breast cancers: mechanistic insights and clinical potentialExpression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes.Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases.BRMS1 gene expression may be associated with clinico-pathological features of breast cancer.Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.Fascin expression is inversely correlated with breast cancer metastasis suppressor 1 and predicts a worse survival outcome in node-negative breast cancer patients.
P2860
Q24299910-1B8FB214-C5BD-41E3-B8E2-6F53E2E4E878Q26866948-D1F44305-97E1-4370-A414-2E6E00711C4CQ28394526-200FD270-C42A-44A1-A0B8-D19084F23083Q30277146-075E0BE2-DB31-4C44-A3F4-7DFF2AF1FDBFQ30434853-2D0D0D2C-E7FE-4E97-A01D-CDA718E69E8EQ30694507-B79C8449-C18B-439B-9216-31BB49E4FAA4Q33850268-7F8CC98E-86E1-4949-AB4D-830E422D4A83Q34072703-24E50EC3-CB09-4280-ADD3-728D19033F57Q34166924-A7F9FA91-13DD-443C-BB00-E910A0F54586Q34284010-3EA27593-AF35-435A-95F4-02DE095604B0Q34298860-4CBFAE2A-8EDE-42CB-91C9-4E6F5C10B8C5Q34580173-9F13996C-89B8-4F36-94E4-20AF6FC3BEF4Q34766640-D66A5C05-C0B0-4A4A-9944-8A7E41F52AC1Q35374953-78263897-1BD5-4101-B02A-C50D70433A81Q36666948-F64372A2-30FC-4FFA-8324-ADC7DB22D361Q36865586-DEE86862-8960-45CA-A9EC-59B9BE351978Q37405531-F65421E8-AAFD-45AB-87B9-C2A6D9DF3066Q37582063-A54B1796-1A36-419A-9ACB-E51FC71EF20EQ37610995-01A93E1E-8453-4477-BB76-64B4E3915ACBQ38017096-EC35D47D-E543-4892-842A-651796887584Q38578251-17D53F0F-6896-4C45-8228-AF4E9CA011EDQ40202794-B3BA943A-54C1-44D5-8F3E-350F4A8FFBDCQ40256293-7E0ADB53-BE9B-4D82-9399-5183351E9EC3Q44430807-9B34EED0-CD8B-4237-9FC0-9A85DCC54369
P2860
A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A shift from nuclear to cytopl ...... eptor-negative breast cancers.
@ast
A shift from nuclear to cytopl ...... eptor-negative breast cancers.
@en
type
label
A shift from nuclear to cytopl ...... eptor-negative breast cancers.
@ast
A shift from nuclear to cytopl ...... eptor-negative breast cancers.
@en
prefLabel
A shift from nuclear to cytopl ...... eptor-negative breast cancers.
@ast
A shift from nuclear to cytopl ...... eptor-negative breast cancers.
@en
P2093
P2860
P356
P1433
P1476
A shift from nuclear to cytopl ...... eptor-negative breast cancers.
@en
P2093
Andra R Frost
Martin R Johnson
Mick D Edmonds
Natalya Frolova
Robert Seitz
Thomas M Bodenstine
P2860
P2888
P304
P356
10.1159/000228908
P577
2009-07-16T00:00:00Z
P5875
P6179
1011185850